Biotech & AI drug discoveryNature Medicine

Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial

Nature Medicine published a phase 2 trial of perioperative ivonescimab, with or without chemotherapy, in resectable non-small cell lung cancer. The available context provides no results or conclusions from the trial.

AI summary · generated only from source feed metadata; consult original

Source published2026-11-04T00:00:00+00:00

Published here2026-11-05T00:43:51+00:00

Original source

Nature Medicine

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41591-026-04745-4

Original headline

Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.